Supplementary Figures 1 - 6 from RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
Mohammad Aminur Rahman(Unknown), Dong M. Shin(Emory University), A.R.M. Ruhul Amin(Emory University), Lydia Koenig(Emory University), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Sreenivas Nannapaneni(GlaxoSmithKline (United States)), Zhuo Chen(First Affiliated Hospital of Zhengzhou University), Zhibo Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dongsheng Wang(University of California San Diego), Xingming Deng(Emory University), Gabriel Sica(Emory University)
Cited by 0
Related Papers
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899